期刊文献+

Smad4,Smad7在糖尿病大鼠肾脏表达和定位的研究 被引量:1

EXPRESSION AND LOCALIZATION OF Smad4 AND Smad7 IN KIDNEY TI SSUE OF DIABETIC RATS
暂未订购
导出
摘要 目的研究糖尿病大鼠肾组织中转化生长因子β1(transforming growth factor-β1,TGF-β1)和Smad4、Smad7的表达。方法用链脲佐菌素诱导的Wistar糖尿病大鼠为模型,随机分为正常对照组和糖尿病组,每组12只,于给药8周后处死,检测各组大鼠的平均动脉压、血糖、肾功能、24 h尿蛋白;采用逆转录多聚酶链反应(reversetranscription-polymerase chain reaction,RT-PCT)检测TGF-β1及Smad4、Smad7 mRNA表达水平;采用免疫组织化学法检测TGF-β1、Smad4和Smad7蛋白定位表达。结果与对照组比较,糖尿病大鼠平均动脉压、血糖、肾功能、24 h尿蛋白均增加,TGF-β1,Smad4和Smad7 mRNA表达上调,TGF-β1,Smad4和Smad7蛋白表达明显增加,且均有统计学意义(P均<0.01)。结论TGF-β/Smad通路在糖尿病肾病时是激活的。 Objective To investigate expression of transforming growth factor-β1 (TGF-β1 ), Smad4 and Smad7 in kidney tissiue of diabetic rats. Methods Healthy male Wistar rats were divided into two groups randomly, normal control group and strepotozocin induced diabetic rats group(12 rats in each group). The rats were sacrificed after drug administration for eight weeks. Mean arterial pressure, plasma glucose, kidney function, 24 h urinary protein were observed. The level of TGF-β1, Smad4 and Smad7mRNA were examined by reverse transcription-polymerase chain reaction(RT-PCR). The localization TGF-β1, Smad4 and Smad7 protein were examined by immunohistochemistry staining. Results Compared to normal control group, mean arterial pressure,plasma glucose, kidney function, 24 h urinary protein were significantly increased in diabetic rats group. The levels of TGF-β1 and Smad4,Smad7mRNA were up-regulated as well as the expression of TGF-β1 and Smad4, Smad7 protein. Conclusion TGF-β/Smad signaling is activated in diabetic nephrology.
出处 《河北医科大学学报》 CAS 2005年第5期324-328,共5页 Journal of Hebei Medical University
关键词 糖尿病 转化生长因子Β 大鼠 diabetes kidney transforming growth factor beta rats
  • 相关文献

参考文献12

  • 1丁鹤林,徐明彤,陈黎红,黎锋,邓庆丽,王佑民,傅祖植,程桦,钟光恕.洛沙坦降低糖尿病大鼠肾组织膜3型基质金属蛋白酶mRNA的表达[J].中华内分泌代谢杂志,2002,18(4):264-267. 被引量:16
  • 2孙正达,陈靖,丁爽爽,邱长斌,杨海春,朱蔚钰,马骥,顾勇,林善锬.波生坦和依那普利对糖尿病大鼠肾脏中过氧化物酶体增殖物激活剂受体γ途径的作用[J].中华肾脏病杂志,2003,19(1):43-48. 被引量:11
  • 3Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy[J]. Semin Nephrol,1997,17(2):80-92..
  • 4Awad AS,Webb RL,Carey RM,et al.Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats[J].Am J Hypertens,2005,4(18):557-565..
  • 5Massague J, Wotton D. Transcriptional control by TGF-β/Smad signaling[J]. EMBO J, 2000, 19(2):1745-1754..
  • 6Furuse Y,Hashimoto N,Maekawa M,et al.Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model,OLETF rats[J].Nephron Exp Nephrol,2004,98(3):100-108..
  • 7Hong SW, Isono M,Chen S, et al. Increased glomerular and tubular expression of transforming growth factor-beta, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse[J]. Am J Pathol,2001,158(5):1653-1663..
  • 8Isono M, Chen S, Hong SW, et al. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediate TGF-beta-induced fibronectin in mesangial[J].Biochem Biophys Res Commun, 2002,296(5):1356-1365..
  • 9Huang HC, Preisig PA. G1 kinase and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth[J].Kidney Int, 2001,58(1):162-172..
  • 10Koya D, Haneda M, Nakagawa H, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes[J]. FASEB J,2000,14(2):439-447..

二级参考文献26

  • 1McLenan SV, Fisher EJ, Yue DK, et al. High glucose concentration causes a decrease in mesangium degradation. Diabetes, 1994,43:1041-1045.
  • 2Davis M, Martin J, Thomas GJ, et al. Proteinase and glomerular matrix turnover. Kidney Int, 1992,41:671-678.
  • 3McLenan SV, Martell SY, Yue DK, et al. High glucose concentration inhibits the membrane metalloproteinase by mesangial cells: possible role in mesangial accumulation. Diabetologia, 2000,43:642-648.
  • 4McLenan SV, Yue DK, Turtle JR, et al. Effects of glucose on matrix metalloproteinase activity in mesangial cells. Nephron, 1998,79:293-298.
  • 5Reckelhoff JF, Tygart VL, Racusen LC, et al. Glomerular metalloproteinase activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP). Life Sci, 1994,55:941-950.
  • 6Kitamura M, Kiturama A, Mitarai T, et al. Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem Biophys Res Commun, 1992,185:1055-1061.
  • 7Lupia E, Elliot SJ, Lenz O, et al. IGF1 decreases collagen degradation in diabetic NOD mesangial cells. Diabetes, 1999,48:1638-1644.
  • 8Del Prete D, Angliani F, Forino M, et al. Down regulation of glomerular matrix metalloproteinase-2 in human NIDDM. Diabetologia, 1997,40:1449-1454.
  • 9Bariscosv WH, Cortez SL, Deboisblanc M, et al. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol, 1999,10:790-795.
  • 10Kagami S, Kuroda T, Odada K, et al. Dual effects of angiotensin on the plasminogen/plasmin system in rat mesangial cells. Kidney Int, 1997,51:664-671.

共引文献23

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部